My response to the recent NEJM editorial on commercial personal genomics companies:
…many [personal genomics customers] will march into their doctors’ offices looking for help reading their genomic tea leaves. Most physicians, at least for the moment, are ill-equipped to deal with this. But does that mean the appropriate response is to simply pat patients on the head and tell them to wait a few years until the New England Journal says it’s OK?
That strikes me as both unproductive and naive.
Read the rest here.